Medical Cyclotron Market Segmentation:
End user Segment Analysis
In terms of end users, the hospital segment is anticipated to dominate the medical cyclotron market with a share of 45.3% over the assessed period. This proprietorship majorly stems from its pivotal role in availing advanced diagnosis and treatment under one roof as a centralized system for healthcare delivery. Additionally, the continuous government investments in infrastructural development in the medical industry incorporate the reinforcement and accommodation of PET/CT scans and radiopharmaceutical therapies. Thus, the steady capital influx secures a major position for hospitals in revenue generation in this sector. Moreover, its captivity over a higher volume of cyclotron installations and isotope consumption is also fueling its dominance.
Type Segment Analysis
Based on type, the high-energy cyclotrons segment is expected to garner a significant share of 42.4% in the medical cyclotron market throughout the forecasted timeframe. The increasing worldwide utilization of proton therapy for cancer treatment is the primary driver behind its accelerated augmentation toward leadership. In this regard, the International Atomic Energy Agency (IAEA) predicted the number of proton therapy centers, operating across the globe, to surpass 61 by the end of 2035. Furthermore, continuous funding from dedicated healthcare authorities is acting as a financial cushion for this segment, fostering a greater scope of innovation. Testifying this, the National Cancer Institute estimated a net of USD 2.9 billion worth of fundraising for proton cyclotrons by 2030.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Application |
|
|
End user |
|
